Prospective cohort study to evaluate safety (three days post vaccination) and immunogenicity (measured 21 days post vaccination) of one dose of Butantan Influenza vaccine.
Prospective study to evaluate the safety and immunogenicity of Butantan Influenza seasonal vaccine.